and

IDEMIA Secure Transactions and Hyundai Motor Group Partner to Deploy Advanced Global Automotive Connectivity Solution

COURBEVOIE, France, Feb. 24, 2026 /PRNewswire/ -- IDEMIA Secure Transactions (IST), a global leader in connectivity and security solutions, is…

3 weeks ago

LIXIL Reaches Major Milestone in Impact Strategy, Improving Sanitation and Hygiene for 103 Million People Globally

TOKYO, Feb. 23, 2026 /PRNewswire/ -- LIXIL Corporation ("LIXIL", TSE Code: 5938), maker of pioneering water and housing products, today…

3 weeks ago

ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options

Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate –…

3 weeks ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.423 Million Tokens, and Total Crypto and Total Cash Holdings of $9.6 Billion

Bitmine has 3,040,483 staked ETH, representing $6.0 billion at $1,958 per ETH; MAVAN staking solution on track to launch Q1…

3 weeks ago

Versos AI Launches the First End-to-End Solution for Preparing and Licensing Video Training Data for AI

SAINT JOHN, New Brunswick, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Versos AI Inc. today announced the launch of the Video…

3 weeks ago

GovSignals Achieves DoW IL5 Authorization with Second Front Systems, Bringing Secure Acquisition AI to Defense and Federal Missions

NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- GovSignals, the acquisition AI platform for government contracting, and Second Front Systems…

3 weeks ago

AI-focused DreamzTech Solutions named to TIME’s Fastest-Growing Companies 2026 list and Forbes DGEMS 2025 Select 200

KOLKATA, India, Feb. 23, 2026 /PRNewswire/ -- DreamzTech Solutions announced that it has been named to TIME & Statista's India's…

3 weeks ago

Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones

Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions,…

3 weeks ago

U.S. Food and Drug Administration (FDA) Accepts Tevas New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-‘749) for the Once-Monthly Treatment of Schizophrenia in Adults

Olanzapine long-acting injectable (LAI) suspension (TEV-'749) has the potential to offer the efficacy of olanzapine in a once-monthly, subcutaneous formulation1If…

3 weeks ago

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- VERSES…

3 weeks ago